The Gen-3 Oncology Drug Engine
AI grounded in living human tumor spacial biology(NAMS)
////////////////
Drug discovery is broken.
Katamaran is fixing it.
For every 20 cancer drugs in trials, 19 fail. Multi-Billion Dollar Failures.
We cure cancer in mice and petri dishes, but these results do not translate to human patients.
Missing the Tumor Microenvironment (TME) and 3D architecture
Result: Al trained on this noise hallucinates better failures.
Our Collaborators
October 10, 2017
////////////////
Featured News
April 9, 2024
Aug 1, 2025
October 10, 2017
For more news
October 10, 2017
What Experts Are Saying
“Head and neck cancers are extremely common but low awareness and non-specific symptoms delay diagnosis. When caught early they have excellent cure rates. Precision therapies are becoming more crucial as a one size fits all approach is ineffective.”
-Dr. Narayana Subramaniam
Lead Consultant, Head & Neck Oncology, Aster Hospitals, Bangalore
+
+
+
////////////////
We’re looking for collaborators, investors, and visionary scientists. Reach out and be part of the mission.
Quick Links
Our Address
India :
Unit, #603, 6th floor, Sigmasoft tech park, Gamma block, Whitefeild, Bengaluru, Karnataka, 560066
US :
Unit 419,180 talmadge rd, Edison nj 08817
UK :
41 Clooney Terrace, Londonderry, Northern Ireland, BT47 6AP
Mail :
Follow Us
© 2026 Katamaran Industries. Innovating for global health equity.
////////////////
+
+
+
Company and Team
“Our platform is engineered to cut development costs by up to two-thirds, accelerate lead selection six fold, and because we validate on patient-derived tumoroids double the odds a therapy reaches the clinic.”
- Arun Asaithambi, Ph.D. Founder
Arun Asaithambi, Ph.D.
Founder and CEO
Anand Asaithambi,
Co-Founder
Research labs
+
+
+